Thorne HealthTech Total Debt vs. Revenue

THRNDelisted Stock  USD 6.40  0.48  8.11%   
Considering the key profitability indicators obtained from Thorne HealthTech's historical financial statements, Thorne HealthTech may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Thorne HealthTech's ability to earn profits and add value for shareholders.
For Thorne HealthTech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Thorne HealthTech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Thorne HealthTech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Thorne HealthTech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Thorne HealthTech over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Please note, there is a significant difference between Thorne HealthTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thorne HealthTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thorne HealthTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Thorne HealthTech Revenue vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Thorne HealthTech's current stock value. Our valuation model uses many indicators to compare Thorne HealthTech value to that of its competitors to determine the firm's financial worth.
Thorne HealthTech is rated below average in total debt category among its peers. It also is rated below average in revenue category among its peers totaling about  4.86  of Revenue per Total Debt. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Thorne HealthTech's earnings, one of the primary drivers of an investment's value.

Thorne Total Debt vs. Competition

Thorne HealthTech is rated below average in total debt category among its peers. Total debt of Consumer Staples industry is at this time estimated at about 15.51 Billion. Thorne HealthTech adds roughly 47.03 Million in total debt claiming only tiny portion of stocks in Consumer Staples industry.
Total debt  Valuation  Revenue  Capitalization  Workforce

Thorne Revenue vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Thorne HealthTech

Total Debt

 = 

Bonds

+

Notes

 = 
47.03 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Thorne HealthTech

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
228.73 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Thorne Revenue vs Competition

Thorne HealthTech is rated below average in revenue category among its peers. Market size based on revenue of Consumer Staples industry is at this time estimated at about 45.95 Billion. Thorne HealthTech adds roughly 228.73 Million in revenue claiming only tiny portion of stocks in Consumer Staples industry.

Thorne HealthTech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Thorne HealthTech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Thorne HealthTech will eventually generate negative long term returns. The profitability progress is the general direction of Thorne HealthTech's change in net profit over the period of time. It can combine multiple indicators of Thorne HealthTech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.

Thorne Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Thorne HealthTech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Thorne HealthTech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Thorne HealthTech's important profitability drivers and their relationship over time.

Use Thorne HealthTech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.

Thorne HealthTech Pair Trading

Thorne HealthTech Pair Trading Analysis

The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Thorne HealthTech position

In addition to having Thorne HealthTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Long Short Funds Thematic Idea Now

Long Short Funds
Long Short Funds Theme
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine